ArticleBMC infectious diseases2026
Thirty-day hospital readmission and its determinants among patients with severe community-acquired pneumonia: a prospective cross-sectional study in Northwest Ethiopia.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHospital readmissions are a frequent complication of community-acquired pneumonia (CAP), resulting in significant clinical and economic burdens. In Ethiopia, data on 30-day readmissions and related factors are lacking. This study aimed to determine the prevalence and factors associated with 30-day all-cause readmission after severe CAP hospitalization at the University of Gondar Comprehensive Specialized Hospital (UOGCSH).
methodsA cross-sectional study was conducted From July 1, 2023, to June 30, 2024, among 177 patients with severe CAP who had been discharged alive from the UOGCSH. Patients were selected using a consecutive sampling technique, and severe CAP was defined according to the Infectious Diseases Society of America (IDSA) criteria. Multivariable binary logistic regression was used to identify factors associated with 30-day all-cause hospital readmission, and the results were reported with a 95% CI. Statistical significance was set at p < 0.05.
resultsThe prevalence of 30-day all-cause hospital readmission was 29.9% (95% CI: 23.3 to 37.3); of those, the majority (71.7%) were readmitted within two weeks. Chronic obstructive pulmonary disease (AOR = 4.51; 95% CI: 1.19 - 17.15), fever (AOR = 3.12; 95% CI: 1.26 - 7.73), admission with ≥3 comorbidities (AOR = 2.68; 95% CI: 1.11 - 6.50), presence of ≥ 1 clinical instability factor at discharge (AOR = 2.54; 95% CI: 1.06 - 6.13), complications of severe CAP, including parapneumonic effusion (AOR = 3.13; 95% CI: 1.26 - 7.77) and respiratory failure (AOR = 4.36; 95% CI: 1.74 - 10.93) were significantly associated with 30-day all-cause hospital readmission.
conclusionsMore than a quarter of patients hospitalized for severe CAP were readmitted within 30 days, and nearly two-thirds were readmitted within two weeks. Patients with severe CAP who were admitted with pulmonary disease, multiple comorbidities, discharged with clinical instability, and developed severe CAP complications were more likely to be readmitted to the hospital. Thus, the provision of optimized in-hospital care, clear discharge planning, post-discharge follow-up, patient education, medication reconciliation, and vaccination can reduce readmission rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.